Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Single Cell Analysis
Current Bioinformatics Trends in Single-Cell Data Analysis: Good Practice Makes Perfect
Good quality samples are integral to single-cell data analysis, but maintaining sample integrity presents a logistical hurdle for bioinformatics teams worldwide. Read on to learn about how senior healthcare researchers circumvent the issues associated with sample degradation.
Clinical Development
Non-Invasive Biomarkers: Aiding Clinical Qualification of Prognostics and Monitoring Biomarkers for Liver Cirrhosis
In this Commentary, we explore how non-invasive biomarkers may be used to diagnose pre-symptomatic NASH in patients without them undergoing invasive biopsies.
Single Cell Analysis
Single-Cell Transcriptomics and Implications for COVID-19 Severity
The expression of the protein coding gene CXCR6 was observed to be significantly lower in patients with severe cases of COVID-19, suggesting a genetic correlation in severe cases.
Clinical Development
The Applicability of Clinical Biomarkers for NASH and Fibrosis
Archana Vijayakumar, Senior Research Scientist I of Fibrosis at Gilead, presents on understanding disease progression and therapeutic efficacy in preclinical models for NASH.